Magnesium and Cognition After Stroke
Recruiting
Observational Study
Stroke
Cognition
Magnesium
Neurologic Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- BDH-Klinik Hessisch Oldendorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients.
Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ischemic/hemmorhagic stroke
* written consent form
Exclusion Criteria:
* pre-existing dementia or cognitive impairment before stroke onset
* pre-existing mental disorder (depression) or present/prior long-term treatment (\> 6 months) with psychotropic drugs
* pre-existing ma…
Contacts
Jens D Rollnik, Prof.
0049 5152 781 231
CONTACT